Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Elite Pharma Inc (ELTP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 71,425
  • Shares Outstanding, K 802,530
  • Annual Sales, $ 9,640 K
  • Annual Income, $ 3,810 K
  • 36-Month Beta 0.31
  • Price/Sales 9.89
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 06/13/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0801 +11.11%
on 06/15/18
0.1045 -14.83%
on 06/04/18
+0.0020 (+2.30%)
since 05/18/18
3-Month
0.0800 +11.25%
on 04/09/18
0.1100 -19.09%
on 03/20/18
-0.0140 (-13.59%)
since 03/16/18
52-Week
0.0560 +58.93%
on 10/27/17
0.2090 -57.42%
on 06/19/17
-0.1030 (-53.65%)
since 06/16/17

Most Recent Stories

More News
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2018 and Provides Conference Call Information

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, announced results for the fiscal year...

ELTP : 0.0890 (-3.16%)
Elite Pharmaceuticals, Inc. Announces Passing of Board Member Eugene Pfeifer

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP) today announced that a member of its Board of Directors, Eugene Pfeifer, passed away on Sunday, June 10, 2018. Mr. Pfeifer had been...

ELTP : 0.0890 (-3.16%)
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Year-end Financial Results on June 15, 2018

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche generic products, announced today that...

ELTP : 0.0890 (-3.16%)
Elite Pharmaceuticals and SunGen Pharma File ANDA for Extended-Release CNS Stimulant

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, today announced that it has filed an...

ELTP : 0.0890 (-3.16%)
Elite Pharmaceuticals Announces Strategic Marketing Alliance with Glenmark Pharmaceuticals, Inc., USA

Elite Pharmaceuticals, Inc (OTCBB:ELTP) announced today the signing of a license, manufacturing, and supply agreement with Glenmark Pharmaceuticals, Inc., USA to market two Elite generic products in the...

ELTP : 0.0890 (-3.16%)
New Research: Key Drivers of Growth for Bioheart and Elite Pharmaceuticals - Factors of Influence, Major Initiatives and Sustained Production

NEW YORK, NY / ACCESSWIRE / March 7, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of Bioheart Inc. (OTCQB: USRM) and Elite Pharmaceuticals Inc. (OTCQB:...

ELTP : 0.0890 (-3.16%)
USRM : 0.0311 (-5.76%)
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2018 Ended December 31, 2017

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, announced results for the third quarter...

ELTP : 0.0890 (-3.16%)
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Third Quarter Financial Results on February 12, 2018

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche generic products, announced today that...

ELTP : 0.0890 (-3.16%)
Global Substance Abuse and Addiction Treatment Market Projected to Grow

According to a report by BCC research the global substance abuse and addiction treatment market has the potential to reach $4.4 billion annually by 2021. The main reason for the global rise in substance...

IMUC : 0.26 (-3.33%)
BICX : 0.1385 (+2.59%)
ELTP : 0.0890 (-3.16%)
DRRX : 2.17 (-1.36%)
TTNP : 1.01 (-3.35%)
Elite Pharmaceuticals Reports Positive Topline Results from SequestOx(TM) Pilot Study

Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today reported positive topline results from a pilot study conducted for SequestOx(TM), Elite's immediate release Oxycodone Hydrochloride...

ELTP : 0.0890 (-3.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade ELTP with:

Key Turning Points

2nd Resistance Point 0.0940
1st Resistance Point 0.0915
Last Price 0.0890
1st Support Level 0.0860
2nd Support Level 0.0830

See More

52-Week High 0.2090
Fibonacci 61.8% 0.1506
Fibonacci 50% 0.1325
Fibonacci 38.2% 0.1144
Last Price 0.0890
52-Week Low 0.0560

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar